Skip to main content
Clinical Trials/NCT00293605
NCT00293605
Completed
Not Applicable

Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip Arthroplasty

Sheffield Teaching Hospitals NHS Foundation Trust1 site in 1 country120 target enrollmentStarted: January 2004Last updated:
ConditionsOsteoarthritis

Overview

Phase
Not Applicable
Status
Completed
Enrollment
120
Locations
1
Primary Endpoint
Proximal femoral BMD change over 2 years measured by DXA

Overview

Brief Summary

Total hip replacement is a common procedure for the treatment of osteoarthrosis of the hips, the aims of this study are to determine the effect of implant stem design on bone quality surrounding the implant using three stem designs that are routinely implanted at this hospital.

Detailed Description

120 patients will undergo routine hip replacements using either the C-Stem, Exeter Stem or Charnley stem implants. Patients will be clinically evaluated pre-operatively and randomised to one of the three implants. Post-operatively, patients will be clinically reviewed for 2 years using bone mineral density scans, radiological review, blood and urine analysis for bone markers and validated questionnaires to assess clinical data (Oxford Hip and Harries Hip). Patients will be assessed for prothesis migration using the EBRA methods.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients must be aged 60 yrs or more uncomplicated primary or secondary osteoarthritis of the hip undergoing unilateral cemented total hip arthroplasty using a metal on polyethylene bearing couple.

Exclusion Criteria

  • metabolic bone disorders, systemic disorders such as rheumatoid arthritis and patients who have taken pharmacological doses of oral steroids, hormone replacement therapy, tamoxifen, calcium or vitamin D supplements within the last year. Patients with a prior history of bisphosphonates and women of child bearing age.

Outcomes

Primary Outcomes

Proximal femoral BMD change over 2 years measured by DXA

Time Frame: 2 years

Secondary Outcomes

  • Clinical Evaluation using patient centered questionnaire (Oxford Hip Score)(2 years)
  • Surgeon centered clinical assessment (Harris Hip Score)(2 years)
  • Plain radiographic assessment(2 years)
  • Femoral prosthetic stem y-axis migration (subsidence), ans stem/shaft angulation change measured by EBRA.(2 years)
  • Biochemical markers of bone formation and resorption measured from serum and urine samples using the Elecsys system.(2 years)

Investigators

Study Sites (1)

Loading locations...

Similar Trials